CTLA4 and breast cancer: Another study demonstrated that 5-aza-2’-deoxycytidine significantly enhanced the tumor cell-killing effects of MAGE-As co-antigen peptide-specific CTLs and anti-CTLA-4 monoclonal antibody in BC cells (163).